Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice.
about
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.Prostaglandin E2 excitatory effects on guinea pig urinary bladder smooth muscle: a novel regulatory mechanism mediated by large-conductance voltage- and Ca2+-activated K+ channelsA non-anesthetized mouse model for recording sensory urinary bladder activity.The effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder.Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in ratsFluorescent Human EP3 Receptor AntagonistsProstaglandin E2 induces spontaneous rhythmic activity in mouse urinary bladder independently of efferent nerves.Pathophysiology and animal modeling of underactive bladder.Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious ratRationale for the use of prostaglandins and phosphodiesterase inhibitors in the treatment of functional bladder disorders.Changes in nerve-mediated contractility of the lower urinary tract in a mouse model of premature ageing.Effect of Selective Prostaglandin E2 EP2 Receptor Agonist CP-533,536 on Voiding Efficiency in Rats with Midodrine-Induced Functional Urethral Obstruction.Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate.Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.The role of prostanoids in urinary bladder physiology.Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery.Inhibitory Effects of Urothelium-related Factors.
P2860
Q33557964-CC87C10F-B1E7-451A-83B3-BD30A4920A33Q33934488-9BB1D323-6E94-45FA-B56B-93EF97B6E042Q34434821-3214773F-F2DE-4C2A-880A-F381C8EF59FCQ34578718-B7078072-CDF6-4A76-8585-0FAD1503E769Q35008053-315D6501-7D58-421E-9F03-288FD3570813Q35181917-75165EF0-27E5-42D6-BC1B-5BAA07C2B104Q35708152-7B77635C-A574-41F6-B94D-55186A49722BQ35747930-C471EC6C-C5BE-4187-A818-B36A21533095Q37481262-14B05935-5082-49CD-918D-ECBBF0530B47Q37639128-73D4CA89-44E8-4E83-9175-94C9F4541EE7Q37665600-9937F040-55FC-4E09-A65E-A9C41B9823C7Q39173562-16EFF220-C7E6-4B87-8BBC-969A4CF4205FQ41997597-AB35F9BB-2B96-434F-86E5-85662264968CQ43744872-9EEEB63E-0CED-4372-8BFC-BFC6A06EF0A6Q44830354-142F7102-2F7E-41CD-BE24-7BE5C0DD8E2CQ47997163-5C03311A-FE23-404F-925D-FBD4A2D27D9BQ50754128-8B6C2C6E-D429-4D07-B8B5-489C31983B85
P2860
Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@en
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@nl
type
label
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@en
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@nl
prefLabel
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@en
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@nl
P2093
P2860
P1476
Enhanced bladder capacity and ...... in EP3 receptor knockout mice.
@en
P2093
Blake A Misajet
Gerald P McCafferty
Kevin S Thorneloe
Nicholas J Laping
Richard M Edwards
P2860
P304
P356
10.1152/AJPRENAL.00054.2008
P577
2008-05-28T00:00:00Z